American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients

Benjamin, 2018, Heart disease and stroke statistics-2018 update: a report from the American Heart Association [published correction appears in Circulation. 2018;137(12):e493], Circulation, 137, e67 Heit, 2002, Venous thromboembolism epidemiology: implications for prevention and management, Semin Thromb Hemost, 28, 3, 10.1055/s-2002-32312 Heit, 2002, Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study, Arch Intern Med, 162, 1245, 10.1001/archinte.162.11.1245 Zarowitz, 2010, Thrombotic risk and immobility in residents of long-term care facilities, J Am Med Dir Assoc, 11, 211, 10.1016/j.jamda.2009.11.006 Cannegieter, 2012, Travel-related thrombosis, Best Pract Res Clin Haematol, 25, 345, 10.1016/j.beha.2012.07.008 Folsom, 2007, Frailty and risk of venous thromboembolism in older adults, J Gerontol A Biol Sci Med Sci, 62, 79, 10.1093/gerona/62.1.79 van Stralen, 2008, Minor injuries as a risk factor for venous thrombosis, Arch Intern Med, 168, 21, 10.1001/archinternmed.2007.5 Schünemann, 2014, Guidelines 2.0: systematic development of a comprehensive checklist for a successful guideline enterprise, CMAJ, 186, E123, 10.1503/cmaj.131237 Committee on Standards for Developing Trustworthy Clinical Practice Guidelines, Board on Health Care Services, 2011 Qaseem, 2012, Board of Trustees of the Guidelines International Network. Guidelines International Network: toward international standards for clinical practice guidelines, Ann Intern Med, 156, 525, 10.7326/0003-4819-156-7-201204030-00009 Schünemann, 2015, Guidelines International Network: principles for disclosure of interests and management of conflicts in guidelines, Ann Intern Med, 163, 548, 10.7326/M14-1885 Alonso-Coello, 2016, GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelines, BMJ, 353, i2089, 10.1136/bmj.i2089 Alonso-Coello, 2016, GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction, BMJ, 353, i2016, 10.1136/bmj.i2016 Atkins, 2004, Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches The GRADE Working Group, BMC Health Serv Res, 4, 38, 10.1186/1472-6963-4-38 Guyatt, 2011, GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables, J Clin Epidemiol, 64, 383, 10.1016/j.jclinepi.2010.04.026 Guyatt, 2008, GRADE: an emerging consensus on rating quality of evidence and strength of recommendations, BMJ, 336, 924, 10.1136/bmj.39489.470347.AD Schünemann, 2003, Letters, numbers, symbols and words: how to communicate grades of evidence and recommendations, CMAJ, 169, 677 Schünemann, 2016, GRADE Guidelines: 16. GRADE evidence to decision frameworks for tests in clinical practice and public health, J Clin Epidemiol, 76, 89, 10.1016/j.jclinepi.2016.01.032 Barbar, 2017, Scoring systems for estimating risk of venous thromboembolism in hospitalized medical patients, Semin Thromb Hemost, 43, 460, 10.1055/s-0036-1597901 National Institute for Health and Clinical Excellence Stein, 2005, Trends in the incidence of pulmonary embolism and deep venous thrombosis in hospitalized patients, Am J Cardiol, 95, 1525, 10.1016/j.amjcard.2005.02.030 Hull, 2013, Venous thromboembolism in elderly high-risk medical patients: time course of events and influence of risk factors, Clin Appl Thromb Hemost, 19, 357, 10.1177/1076029613481105 Geerts, 2008 Nicolaides, 2013, Prevention and treatment of venous thromboembolism--International Consensus Statement, Int Angiol, 32, 111 Agency for Healthcare Research and Quality. Preventing hospital-acquired venous thromboembolism: a guide for effective quality improvement. https://www.mnhospitals.org/Portals/0/Documents/ptsafety/vte/vtguide.pdf. Accessed 14 December 2017. Flanders, 2014, Hospital performance for pharmacologic venous thromboembolism prophylaxis and rate of venous thromboembolism: a cohort study, JAMA Intern Med, 174, 1577, 10.1001/jamainternmed.2014.3384 Mahan, 2013, Thromboprophylaxis patterns, risk factors, and outcomes of care in the medically ill patient population, Thromb Res, 132, 520, 10.1016/j.thromres.2013.08.013 Cohen, 2006, Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial, BMJ, 332, 325, 10.1136/bmj.38733.466748.7C Leizorovicz, 2004, Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients, Circulation, 110, 874, 10.1161/01.CIR.0000138928.83266.24 Samama, 1999, A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients, N Engl J Med, 341, 793, 10.1056/NEJM199909093411103 Cohen, 2008, Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study, Lancet, 371, 387, 10.1016/S0140-6736(08)60202-0 Greene, 2016, Validation of risk assessment models of venous thromboembolism in hospitalized medical patients, Am J Med, 129, 1001.e9, 10.1016/j.amjmed.2016.03.031 Stuck, 2017, Risk assessment models for venous thromboembolism in acutely ill medical patients. A systematic review, Thromb Haemost, 117, 801, 10.1160/TH16-08-0631 Zakai, 2013, Venous thrombosis risk assessment in medical inpatients: the medical inpatients and thrombosis (MITH) study, J Thromb Haemost, 11, 634, 10.1111/jth.12147 Barbar, 2010, A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score, J Thromb Haemost, 8, 2450, 10.1111/j.1538-7836.2010.04044.x Spyropoulos, 2011, Predictive and associative models to identify hospitalized medical patients at risk for VTE, Chest, 140, 706, 10.1378/chest.10-1944 Nendaz, 2014, Multicentre validation of the Geneva Risk Score for hospitalised medical patients at risk of venous thromboembolism. Explicit ASsessment of Thromboembolic RIsk and Prophylaxis for Medical PATients in SwitzErland (ESTIMATE), Thromb Haemost, 111, 531, 10.1160/TH13-05-0427 Rosenberg, 2014, External validation of the risk assessment model of the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) for medical patients in a tertiary health system, J Am Heart Assoc, 3, e001152, 10.1161/JAHA.114.001152 Decousus, 2011, Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators, Chest, 139, 69, 10.1378/chest.09-3081 Hostler, 2016, Validation of the International Medical Prevention Registry on Venous Thromboembolism bleeding risk score, Chest, 149, 372, 10.1378/chest.14-2842 Rosenberg, 2016, External validation of the IMPROVE bleeding risk assessment model in medical patients, Thromb Haemost, 116, 530, 10.1160/TH16-01-0003 Cohen, 2016, Extended thromboprophylaxis with betrixaban in acutely ill medical patients, N Engl J Med, 375, 534, 10.1056/NEJMoa1601747 Cohen, 2014, D-dimer as a predictor of venous thromboembolism in acutely ill, hospitalized patients: a subanalysis of the randomized controlled MAGELLAN trial, J Thromb Haemost, 12, 479, 10.1111/jth.12515 Gibson CM , SpyropoulosAC, CohenAT, et al. The IMPROVEDD VTE risk score: incorporation of D-Dimer into the IMPROVE score to improve venous thromboembolism risk stratification. Available at: http://www.thieme-connect.de/DOI/DOI?10.1055/s-0037-1603929. Accessed 6 August 2017. Lo, 2009 Akl, 2014, Considering intellectual, in addition to financial, conflicts of interest proved important in a clinical practice guideline: a descriptive study, J Clin Epidemiol, 67, 1222, 10.1016/j.jclinepi.2014.05.006 Guyatt, 2010, The vexing problem of guidelines and conflict of interest: a potential solution, Ann Intern Med, 152, 738, 10.7326/0003-4819-152-11-201006010-00254 Schünemann, 2009, An official American Thoracic Society Policy statement: managing conflict of interest in professional societies, Am J Respir Crit Care Med, 180, 564, 10.1164/rccm.200901-0126ST Brożek J , NowakA, KunstmanP, SchünemannHJ. GRADEpro Guideline Development Tool (computer program). Available at: www.guidelinedevelopment.org. Accessed 5 July 2018. Guyatt, 2011, GRADE guidelines: 2. Framing the question and deciding on important outcomes, J Clin Epidemiol, 64, 395, 10.1016/j.jclinepi.2010.09.012 Ageno, 2016, Nadroparin for the prevention of venous thromboembolism in nonsurgical patients: a systematic review and meta-analysis, J Thromb Thrombolysis, 42, 90, 10.1007/s11239-015-1294-3 Alikhan, 2014, Heparin for the prevention of venous thromboembolism in acutely ill medical patients (excluding stroke and myocardial infarction), CD003747 André, 2007, Prevention of deep venous thrombosis and pulmonary embolism following stroke: a systematic review of published articles, Eur J Neurol, 14, 21, 10.1111/j.1468-1331.2006.01536.x Bump, 2009, How complete is the evidence for thromboembolism prophylaxis in general medicine patients? A meta-analysis of randomized controlled trials, J Hosp Med, 4, 289, 10.1002/jhm.450 Dentali, 2007, Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients, Ann Intern Med, 146, 278, 10.7326/0003-4819-146-4-200702200-00007 Eikelboom, 2008, Effect of fondaparinux 2.5 mg once daily on mortality: A meta-analysis of phase III randomized trials of venous thromboembolism prevention, Eur Heart J Suppl, 10, C8, 10.1093/eurheartj/sun004 Kamphuisen, 2007, What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke?, Thromb Res, 119, 265, 10.1016/j.thromres.2006.03.010 Kanaan, 2007, Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients, Clin Ther, 29, 2395, 10.1016/j.clinthera.2007.11.015 Lederle, 2011, Venous thromboembolism prophylaxis in hospitalized medical patients and those with stroke: a background review for an American College of Physicians Clinical Practice Guideline, Ann Intern Med, 155, 602, 10.7326/0003-4819-155-9-201111010-00008 Lloyd, 2008, Anticoagulant prophylaxis to prevent asymptomatic deep vein thrombosis in hospitalized medical patients: a systematic review and meta-analysis, J Thromb Haemost, 6, 405, 10.1111/j.1538-7836.2007.02847.x Loffredo, 2013, Antithrombotic drugs in acutely ill medical patients: Review and meta-analysis of interventional trials with low-molecular-weight heparin and fondaparinux, Clin Pract, 10, 615, 10.2217/cpr.13.55 Paciaroni, 2011, Efficacy and safety of anticoagulants in the prevention of venous thromboembolism in patients with acute cerebral hemorrhage: a meta-analysis of controlled studies, J Thromb Haemost, 9, 893, 10.1111/j.1538-7836.2011.04241.x Saigal, 2014, Thrombo-prophylaxis in acutely ill medical and critically ill patients, Indian J Crit Care Med, 18, 382, 10.4103/0972-5229.133902 Sandercock, 2015, Anticoagulants for acute ischaemic stroke, Cochrane Database Syst Rev, CD000024 Sandercock, 2008, Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke, Cochrane Database Syst Rev, CD000119 Själander, 2008, Efficacy and safety of anticoagulant prophylaxis to prevent venous thromboembolism in acutely ill medical inpatients: a meta-analysis, J Intern Med, 263, 52, 10.1111/j.1365-2796.2007.01878.x Wein, 2007, Pharmacological venous thromboembolism prophylaxis in hospitalized medical patients: a meta-analysis of randomized controlled trials, Arch Intern Med, 167, 1476, 10.1001/archinte.167.14.1476 International Stroke Trial Collaborative Group, 1997, The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke, Lancet, 349, 1569, 10.1016/S0140-6736(97)04011-7 Chaudhry, 2002, Low molecular weight heparin in acute ischemic stroke, Antiseptic, 99, 31 Dickmann, 1988, Heparin therapy, deep-vein thrombosis and pulmonary embolism after intracerebral hemorrhage, Klin Wochenschr, 66, 1182, 10.1007/BF01727666 Duke, 1986, Intravenous heparin for the prevention of stroke progression in acute partial stable stroke, Ann Intern Med, 105, 825, 10.7326/0003-4819-105-6-825 Duke, 1982, Clinical trial of low-dose subcutaneous heparin for the prevention of stroke progression: natural history of acute partial stroke and stroke-in-evolution [abstract], J Cereb Blood Flow Metabol, 2, 267 Elias, 1990, Prevention of deep venous thrombosis of the leg by a very low molecular weight heparin fraction (CY 222) in patients with hemiplegia following cerebral infarction: a randomized pilot study (30 patients) [in French], Rev Med Intern, 11, 95, 10.1016/S0248-8663(05)80622-8 Hommel, 1998, Fraxiparine in ischaemic stroke study (FISS bis), Cerebrovasc Dis, 8, 19 Kay, 1995, Low-molecular-weight heparin for the treatment of acute ischemic stroke, N Engl J Med, 333, 1588, 10.1056/NEJM199512143332402 Kwiecinski, 1995, A randomized trial of fraxiparine in acute ischaemic stroke, Cerebrovasc Dis, 5, 234 McCarthy, 1986, Low-dose subcutaneous heparin in the prevention of deep-vein thrombosis and pulmonary emboli following acute stroke, Age Ageing, 15, 84, 10.1093/ageing/15.2.84 McCarthy, 1977, Low-dose heparin as a prophylaxis against deep-vein thrombosis after acute stroke, Lancet, 2, 800, 10.1016/S0140-6736(77)90728-0 Pambianco, 1995, Deep vein thrombosis: prevention in stroke patients during rehabilitation, Arch Phys Med Rehabil, 76, 324, 10.1016/S0003-9993(95)80657-1 Pince, 1981 Prins, 1989, Prophylaxis of deep venous thrombosis with a low-molecular-weight heparin (Kabi 2165/Fragmin) in stroke patients, Haemostasis, 19, 245 Sandset, 1990, A double-blind and randomized placebo-controlled trial of low molecular weight heparin once daily to prevent deep-vein thrombosis in acute ischemic stroke, Semin Thromb Hemost, 16, 25 Belch, 1981, Prevention of deep vein thrombosis in medical patients by low-dose heparin, Scott Med J, 26, 115, 10.1177/003693308102600205 Dahan, 1986, Prevention of deep vein thrombosis in elderly medical in-patients by a low molecular weight heparin: a randomized double-blind trial, Haemostasis, 16, 159 Gallus, 1973, Small subcutaneous doses of heparin in prevention of venous thrombosis, N Engl J Med, 288, 545, 10.1056/NEJM197303152881103 Gärdlund, 1996, Randomised, controlled trial of low-dose heparin for prevention of fatal pulmonary embolism in patients with infectious diseases, Lancet, 347, 1357, 10.1016/S0140-6736(96)91009-0 Ibarra-Pérez, 1988, Prevalence and prevention of deep venous thrombosis of the lower extremities in high-risk pulmonary patients, Angiology, 39, 505, 10.1177/000331978803900603 Kakkar, 2011, Low-molecular-weight heparin and mortality in acutely ill medical patients, N Engl J Med, 365, 2463, 10.1056/NEJMoa1111288 Mahé, 2005, Lack of effect of a low-molecular-weight heparin (nadroparin) on mortality in bedridden medical in-patients: a prospective randomised double-blind study, Eur J Clin Pharmacol, 61, 347, 10.1007/s00228-005-0944-3 Lamy, 2002, Economic evaluation of the MEDENOX trial: a Canadian perspective. Medical Patients with Enoxaparin, Can Respir J, 9, 169, 10.1155/2002/310841 Offord, 2004, Economic evaluation of enoxaparin for the prevention of venous thromboembolism in acutely ill medical patients, Pharm World Sci, 26, 214, 10.1023/B:PHAR.0000035887.23072.e5 Pechevis, 2000, Economic evaluation of enoxaparin vs. placebo for the prevention of venous thromboembolism in acutely ill medical patients, Value Health, 3, 389, 10.1046/j.1524-4733.2000.36008.x Diener, 2006, Prophylaxis of thrombotic and embolic events in acute ischemic stroke with the low-molecular-weight heparin certoparin: results of the PROTECT Trial, Stroke, 37, 139, 10.1161/01.STR.0000195182.67656.ee Dumas, 1994, A multicentre, double-blind, randomized study to compare the safety and efficacy of once-daily ORG 10172 and twice-daily low-dose heparin in preventing deep-vein thrombosis in patients with acute ischaemic stroke, Age Ageing, 23, 512, 10.1093/ageing/23.6.512 Hillbom, 2002, Enoxaparin vs heparin for prevention of deep-vein thrombosis in acute ischaemic stroke: a randomized, double-blind study, Acta Neurol Scand, 106, 84, 10.1034/j.1600-0404.2002.01215.x Sherman, 2007, The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison, Lancet, 369, 1347, 10.1016/S0140-6736(07)60633-3 Turpie, 1992, A low-molecular-weight heparinoid compared with unfractionated heparin in the prevention of deep vein thrombosis in patients with acute ischemic stroke. A randomized, double-blind study, Ann Intern Med, 117, 353, 10.7326/0003-4819-117-5-353 Bergmann, 1996, A multicenter randomized double-blind study of enoxaparin compared with unfractionated heparin in the prevention of venous thromboembolic disease in elderly in-patients bedridden for an acute medical illness, Thromb Haemost, 76, 529, 10.1055/s-0038-1650617 Ishi, 2013, Randomised controlled trial for efficacy of unfractionated heparin (UFH) versus low molecular weight heparin (LMWH) in thrombo-prophylaxis, J Assoc Physicians India, 61, 882 Kleber, 2003, Randomized comparison of enoxaparin with unfractionated heparin for the prevention of venous thromboembolism in medical patients with heart failure or severe respiratory disease, Am Heart J, 145, 614, 10.1067/mhj.2003.189 Lechler, 1996, The venous thrombotic risk in non-surgical patients: epidemiological data and efficacy/safety profile of a low-molecular-weight heparin (enoxaparin), Haemostasis, 26, 49 Riess, 2010, A randomized, double-blind study of certoparin vs. unfractionated heparin to prevent venous thromboembolic events in acutely ill, non-surgical patients: CERTIFY Study, J Thromb Haemost, 8, 1209, 10.1111/j.1538-7836.2010.03848.x Schellong, 2010, An open-label comparison of the efficacy and safety of certoparin versus unfractionated heparin for the prevention of thromboembolic complications in acutely ill medical patients: CERTAIN, Expert Opin Pharmacother, 11, 2953, 10.1517/14656566.2010.521498 Amin, 2009, Clinical and economic outcomes in patients at risk of venous thromboembolism receiving appropriate enoxaparin or unfractionated heparin prophylaxis, Thromb Haemost, 102, 321 Deitelzweig, 2008, Comparison of the two-year outcomes and costs of prophylaxis in medical patients at risk of venous thromboembolism, Thromb Haemost, 100, 810, 10.1160/TH08-04-0248 Fowler, 2014, Cost-effectiveness of dalteparin vs unfractionated heparin for the prevention of venous thromboembolism in critically ill patients, JAMA, 312, 2135, 10.1001/jama.2014.15101 Leykum, 2006, Cost utility of substituting enoxaparin for unfractionated heparin for prophylaxis of venous thrombosis in the hospitalized medical patient, J Hosp Med, 1, 168, 10.1002/jhm.97 Lloyd, 2001, Economic evaluation of the use of enoxaparin for thromboprophylaxis in acutely ill medical patients, J Med Econ, 4, 99, 10.3111/200104099113 McGarry, 2006, Outcomes of thromboprophylaxis with enoxaparin vs. unfractionated heparin in medical inpatients, Thromb J, 4, 17, 10.1186/1477-9560-4-17 McGarry, 2004, Cost effectiveness of thromboprophylaxis with a low-molecular-weight heparin versus unfractionated heparin in acutely ill medical inpatients, Am J Manag Care, 10, 632 Schädlich, 2006, Cost effectiveness of enoxaparin as prophylaxis against venous thromboembolic complications in acutely ill medical inpatients: modelling study from the hospital perspective in Germany, Pharmacoeconomics, 24, 571, 10.2165/00019053-200624060-00005 Shorr, 2007, Low-molecular weight heparin for deep vein thrombosis prophylaxis in hospitalized medical patients: results from a cost-effectiveness analysis, Blood Coagul Fibrinolysis, 18, 309, 10.1097/MBC.0b013e328099af58 Wilbur, 2011, Low-molecular-weight heparin versus unfractionated heparin for prophylaxis of venous thromboembolism in medicine patients--a pharmacoeconomic analysis, Clin Appl Thromb Hemost, 17, 454, 10.1177/1076029610376935 Alhazzani, 2013, Heparin thromboprophylaxis in medical-surgical critically ill patients: a systematic review and meta-analysis of randomized trials, Crit Care Med, 41, 2088, 10.1097/CCM.0b013e31828cf104 Fraisse, 2000, Nadroparin in the prevention of deep vein thrombosis in acute decompensated COPD, Am J Respir Crit Care Med, 161, 1109, 10.1164/ajrccm.161.4.9807025 Kapoor, 1999, Subcutaneous heparin prophylaxis significantly reduces the incidence of venous thromboembolic events in the critically ill [abstract], Crit Care Med, 27 Shorr, 2009, Venous thromboembolism in critically ill patients. Observations from a randomized trial in sepsis, Thromb Haemost, 101, 139, 10.1160/TH08-07-0468 Cook, 2011, Dalteparin versus unfractionated heparin in critically ill patients, N Engl J Med, 364, 1305, 10.1056/NEJMoa1014475 Goldhaber, 2000, Low molecular weight heparin versus minidose unfractionated heparin for prophylaxis against venous thromboembolism in medical intensive care unit patients: a randomized controlled trial, J Am Coll Cardiol, 35, 325A Guyatt, 2013, GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes, J Clin Epidemiol, 66, 151, 10.1016/j.jclinepi.2012.01.006 Orken, 2009, Prevention of deep venous thrombosis and pulmonary embolism in patients with acute intracerebral hemorrhage, Neurologist, 15, 329, 10.1097/NRL.0b013e3181a93bac Salzman, 1982, Prevention of venous thromboembolism in unstable angina pectoris, N Engl J Med, 306, 991, 10.1056/NEJM198204223061613 Barrera, 2013, Thromboprophylaxis for trauma patients, Cochrane Database Syst Rev, CD008303 Ginzburg, 2003, Randomized clinical trial of intermittent pneumatic compression and low molecular weight heparin in trauma, Br J Surg, 90, 1338, 10.1002/bjs.4309 Knudson, 1992, Thromboembolism following multiple trauma, J Trauma, 32, 2, 10.1097/00005373-199201000-00002 Knudson, 1994, Prevention of venous thromboembolism in trauma patients, J Trauma, 37, 480, 10.1097/00005373-199409000-00025 Knudson, 1996, Use of low molecular weight heparin in preventing thromboembolism in trauma patients, J Trauma, 41, 446, 10.1097/00005373-199609000-00010 Kurtoglu, 2004, Venous thromboembolism prophylaxis after head and spinal trauma: intermittent pneumatic compression devices versus low molecular weight heparin, World J Surg, 28, 807, 10.1007/s00268-004-7295-6 Yanar, 2007, Is intermittent pneumatic compression make low molecular weight heparin more efficient in the prophylaxis of venous thromboembolism in trauma patients, Eur J Trauma Emerg Surg, 33(suppl II), 79 Kurtoglu, 2009, Venous thromboembolism prophylaxis methods in the trauma and emergency surgery intensive care unit patients, J Thromb Haemost, 7, 692 Zhang, 2011, The efficacy of intermittent pneumatic compression in the prevention of venous thromboembolism in medical critically ill patients [in Chinese], Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, 23, 563 Naccarato, 2010, Physical methods for preventing deep vein thrombosis in stroke, Cochrane Database Syst Rev, CD001922 Dennis, 2015, The Clots in Legs Or sTockings after Stroke (CLOTS) 3 trial: a randomised controlled trial to determine whether or not intermittent pneumatic compression reduces the risk of post-stroke deep vein thrombosis and to estimate its cost-effectiveness, Health Technol Assess, 19, 1, 10.3310/hta19760 The CLOTS Trials Collaboration, 2009, Effectiveness of thigh-length graduated compression stockings to reduce the risk of deep vein thrombosis after stroke (CLOTS trial 1): a multicentre, randomised controlled trial, Lancet, 373, 1958, 10.1016/S0140-6736(09)60941-7 Fisher, 1995, Effectiveness of pneumatic leg compression devices for the prevention of thromboembolic disease in orthopaedic trauma patients: a prospective, randomized study of compression alone versus no prophylaxis, J Orthop Trauma, 9, 1, 10.1097/00005131-199502000-00001 Prasad, 1982, Incidence of deep vein thrombosis and the effect of pneumatic compression of the calf in elderly hemiplegics, Age Ageing, 11, 42, 10.1093/ageing/11.1.42 Velmahos, 2005, Electrostimulation for the prevention of deep venous thrombosis in patients with major trauma: a prospective randomized study, Surgery, 137, 493, 10.1016/j.surg.2005.01.010 Dennis, 1993, Efficacy of deep venous thrombosis prophylaxis in trauma patients and identification of high-risk groups, J Trauma, 35, 132, 10.1097/00005373-199307000-00021 Boelig, 2011, Are sequential compression devices commonly associated with in-hospital falls? A myth-busters review using the patient safety net database, J Patient Saf, 7, 77, 10.1097/PTS.0b013e3182110706 Cohen, 2013, Rivaroxaban for thromboprophylaxis in acutely ill medical patients, N Engl J Med, 368, 513, 10.1056/NEJMoa1111096 Goldhaber, 2011, Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients, N Engl J Med, 365, 2167, 10.1056/NEJMoa1110899 Spencer, 2014, Venous thromboembolism in older adults: A community-based study, Am J Med, 127, 530, 10.1016/j.amjmed.2014.02.011 Raskob, 2016, The MARINER trial of rivaroxaban after hospital discharge for medical patients at high risk of VTE. Design, rationale, and clinical implications, Thromb Haemost, 115, 1240, 10.1160/TH15-09-0756 Sharma, 2012, Extended thromboprophylaxis for medically ill patients with decreased mobility: does it improve outcomes?, J Thromb Haemost, 10, 2053, 10.1111/j.1538-7836.2012.04874.x Hull, 2010, Extended-duration venous thromboembolism prophylaxis in acutely ill medical patients with recently reduced mobility: a randomized trial, Ann Intern Med, 153, 8, 10.7326/0003-4819-153-1-201007060-00004 Spyropoulos, 2018, Rivaroxaban for thromboprophylaxis after hospitalization for medical illness, N Engl J Med, 379, 1118, 10.1056/NEJMoa1805090 Modesto-Alapont, 2006, Can home prophylaxis for venous thromboembolism reduce mortality rates in patients with chronic obstructive pulmonary disease? [in Spanish], Arch Bronconeumol, 42, 130, 10.1157/13085562 Reardon, 2013, Incidence of venous thromboembolism in nursing home residents, J Am Med Dir Assoc, 14, 578, 10.1016/j.jamda.2013.02.003 Chandra, 2009, Meta-analysis: travel and risk for venous thromboembolism, Ann Intern Med, 151, 180, 10.7326/0003-4819-151-3-200908040-00129 Philbrick, 2007, Air travel and venous thromboembolism: a systematic review, J Gen Intern Med, 22, 107, 10.1007/s11606-006-0016-0 Kuipers, 2007, Travel and venous thrombosis: a systematic review, J Intern Med, 262, 615, 10.1111/j.1365-2796.2007.01867.x Beam, 2009, Risk of thromboembolism varies, depending on category of immobility in outpatients, Ann Emerg Med, 54, 147, 10.1016/j.annemergmed.2008.10.033 MacCallum, 2009, Air travel and risk of venous thromboembolism: a community-based study, J Thromb Haemost, 7, 162 Chua, 2015, Provoked venous thromboembolism in non-cancer patients: are they the same?, Haematologica, 100, 308 Citak, 2015, Are patients with preoperative air travel at higher risk for venous thromboembolism following primary total hip and knee arthroplasty?, Technol Health Care, 23, 307, 10.3233/THC-150893 Cooper, 2014, Risk of symptomatic venous thromboembolism associated with flying in the early postoperative period following elective total hip and knee arthroplasty, J Arthroplasty, 29, 1119, 10.1016/j.arth.2014.01.005 Kuipers, 2009, Effect of elevated levels of coagulation factors on the risk of venous thrombosis in long-distance travelers, Blood, 113, 2064, 10.1182/blood-2008-06-160135 Kuipers, 2014, The incidence of venous thromboembolism in commercial airline pilots: a cohort study of 2630 pilots, J Thromb Haemost, 12, 1260, 10.1111/jth.12627 Lapostolle, 2009, Gender as a risk factor for pulmonary embolism after air travel, Thromb Haemost, 102, 1165 Timp, 2015, Long-haul travel and the risk of recurrent venous thrombosis, J Thromb Haemost, 13, 725 Tsoran, 2010, Prolonged travel and venous thromboembolism findings from the RIETE registry, Thromb Res, 126, 287, 10.1016/j.thromres.2010.06.015 Kuipers, 2014, The risk of venous thrombosis after air travel: contribution of clinical risk factors, Br J Haematol, 165, 412, 10.1111/bjh.12724 Cushman, 2004, Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology, Am J Med, 117, 19, 10.1016/j.amjmed.2004.01.018 Cannegieter, 2013, Pregnancy and travel-related thromboembolism, Thromb Res, 131, S55, 10.1016/S0049-3848(13)70023-9 Clarke, 2016, Compression stockings for preventing deep vein thrombosis in airline passengers, Cochrane Database Syst Rev, 9, CD004002 World Health Organization. International Travel and Health. Geneva, Switzerland, 2012, World Health Organization World Health Organization, 2007 Cesarone, 2002, Venous thrombosis from air travel: the LONFLIT3 study--prevention with aspirin vs low-molecular-weight heparin (LMWH) in high-risk subjects: a randomized trial, Angiology, 53, 1, 10.1177/000331970205300101 Qaseem, 2011, Venous thromboembolism prophylaxis in hospitalized patients: a clinical practice guideline from the American College of Physicians, Ann Intern Med, 155, 625, 10.7326/0003-4819-155-9-201111010-00011 Kahn, 2012 Liew, 2017, Asian venous thromboembolism guidelines: updated recommendations for the prevention of venous thromboembolism, Int Angiol, 36, 1, 10.23736/S0392-9590.16.03765-2 National Institute for Health and Care Excellence. Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism. https://www.nice.org.uk/guidance/ng89. Accessed 15 April 2018. Agency for Healthcare Research and Quality. Preventing hospital-associated venous thromboembolism: a guide for effective quality improvement. http://www.ahrq.gov/professionals/quality-patient-safety/patient-safety-resources/resources/vtguide/index.html. Accessed 15 April 2018. Schünemann, 2017, GRADE Evidence to Decision (EtD) frameworks for adoption, adaptation, and de novo development of trustworthy recommendations: GRADE-ADOLOPMENT, J Clin Epidemiol, 81, 101, 10.1016/j.jclinepi.2016.09.009